
Mukta Drugs Private Limited
About Mukta Drugs Private Limited
Data last updated:
Mukta Drugs Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical chemical segment of the chemicals sector. It was incorporated on 23 January 2006 and has been in existence for over 20 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24231DL2006PTC145271.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Girish Kumar and Chander Shekhar.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at N – 53 G.K. Part Inew Delhi – 48 New Delhi – 48, Delhi, India.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Mukta Drugs Private Limited's registered office is in New Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressN – 53 G.K. Part Inew Delhi – 48 New Delhi – 48, Delhi, India
- IndustryChemicals, Pharmaceutical Chemical, Other Chemical Product, Manufacturing
To see the full contact details of Mukta Drugs Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Mukta Drugs Private Limited
FY 2024 filings availableFinancial Statement Summary
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | |||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | |||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | |||
| Net Profit Margin | |||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Mukta Drugs Private Limited, buy the company report.
Board of directors of Mukta Drugs Private Limited
Mukta Drugs has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Girish Kumar Also directs: Elder Surgical Private Limited | Director | 23 Jan 2006 | 20 Years 9 Months | Current |
| Chander Shekhar | Director | 23 Jan 2006 | 20 Years 9 Months | Current |
| Raj Kumar Also directs: Elder Surgical Private Limited | Director | 23 Jan 2006 | 20 Years 9 Months | Current |
Auditor
Mukta Drugs Private Limited is audited by VINOD GROVER AND ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| VINOD GROVER AND ASSOCIATES | FY 2017 | 013331N |
Shareholding
The shareholding of Mukta Drugs Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Mukta Drugs Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Mukta Drugs Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Mukta Drugs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Mukta Drugs Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Mukta Drugs Private Limited has 3 board changes on record since 2006: 3 appointments. The latest: Chander Shekhar was appointed as Director on 23 Jan 2006.
Frequently asked questions
Mukta Drugs is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical chemical, within the chemicals industry. It was incorporated on 23 January 2006 (20+ years old) and is registered under CIN U24231DL2006PTC145271.
Mukta Drugs has 3 current directors:
- Girish Kumar - Director
- Chander Shekhar - Director
- Raj Kumar - Director
The latest financial statements of Mukta Drugs on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Mukta Drugs is U24231DL2006PTC145271. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Mukta Drugs was incorporated on 23 January 2006, making it 20+ years old. It is registered with the Registrar of Companies, Delhi.
Chander Shekhar was appointed as Director on 23 Jan 2006. Girish Kumar was appointed as Director on 23 Jan 2006. Raj Kumar was appointed as Director on 23 Jan 2006.
The registered office of Mukta Drugs is at N – 53 G.K. Part Inew Delhi – 48 New Delhi – 48, Delhi, India.
Mukta Drugs operates in the chemicals industry, in the pharmaceutical chemical segment.
The compliance status of Mukta Drugs is compliant as of 25 September 2026. The company is actively filing with the Registrar of Companies.
Mukta Drugs can be reached at its registered office: N – 53 G.K. Part Inew Delhi – 48 New Delhi – 48, Delhi, India.

